ScienceMedia
ScienceMedia Advantage

Marvin R. Brown, MD, Director, has more than 12 years of entrepreneurial experience and is an active investor and Director in numerous early stage companies. As founder and CEO of Alanex Corporation, he led the growth of the company from inception through successful acquisition by Agouron Pharmaceuticals, and subsequently became a Vice President of Warner Lambert. Dr. Brown was a Professor of Medicine and Surgery at the University of California and Co-founder of the Peptide Biology Laboratory at the Salk Institute in La Jolla. Dr. Brown earned his M.D. from the University of Arizona Health Sciences Center and completed his training in medicine at the University of California, San Diego, and his scientific training at the Neuroendocrinology Laboratory of the Salk Institute.

John Chiplin, Ph.D., Director, has broad-based experience in the life science and technology industries, both from an operational and investment perspective. His most recent accomplishment was the corporate reengineering of Arana Therapeutics, a world leading Antibody developer, which resulted in the acquisition of the company by Cephalon for a significant premium to market (March, 2009). Immediately prior to running Arana, Dr. Chiplin was head of the $300M ITI Life Sciences investment fund in the UK. His own investment vehicle, Newstar Ventures Ltd, has funded more than a dozen early stage companies in the past ten years. Dr. Chiplin earned his Pharmacy and Doctoral degrees from the University of Nottingham, UK.


Home | ScienceMedia Advantage | Marketing and Communications Solutions
eLearning Solutions
| Project Portfolio | The Company | Demo Area | Contact Us!

Marketing and Communication Solutions
eLearning Solutions
Project Portfolio
The Company
:Demo Area:
Contact us!